Solid Biosciences Inc.

IPO

Home - Solid Biosciences

Public · Charlestown, United States · Founded 2013 · $150.0M raised

Employees
51–200
Founded
2013
Business Model
B2B
Total Funding
$150.0M
Last Round
$50.0M Series CMar 2017
Rounds
3
Type
Public

About

Solid Biosciences is a precision genetic medicine company focused on advancing a portfolio of gene therapy candidates targeting rare neuromuscular and cardiac diseases, including Duchenne muscular dystrophy. Founded in 2013 after co-founder Ilan Ganot's son was diagnosed with DMD, the company develops AAV-based micro-dystrophin gene therapies and genetic regulator technologies. Its lead program SGT-003 is in active Phase I/II clinical trials.

Summary

Solid Biosciences Inc. is a Biotech company based in Charlestown, United States, founded in 2013. It has raised $150.0M in total across 3 rounds, most recently a $50.0M Series C round in Mar 2017. Investors include RA Capital Management, Bain Capital Life Sciences and Deerfield Management.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

IPOJan 2018
$130.0M

Sign up to see all 4 rounds

Series A through IPO — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Solid Biosciences Inc. on Indexed.vc
<a href="https://indexed.vc/companies/solid-biosciences-inc"><img src="https://indexed.vc/api/badge/company/solid-biosciences-inc" alt="Solid Biosciences Inc. on Indexed.vc" width="260" height="76" /></a>